FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION Masin v. Mylan Laboratories | Secondary Sources | Westlaw

FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION Masin v. Mylan Laboratories | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION Masin v. Mylan Laboratories, Secondary Sources
Skip Page Header

FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION Masin v. Mylan Laboratories

6 No. 7 ANANTILR 4Andrews Antitrust Litigation Reporter (Approx. 3 pages)

FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION Masin v. Mylan Laboratories

6 No. 7 ANANTILR 4Andrews Antitrust Litigation Reporter (Approx. 3 pages)

6 No. 7 Andrews Antitrust Litig. Rep. 4
Andrews Antitrust Litigation Reporter
January 1999
Monopolization
Copyright (c) 1999 Andrews Publications

FTC CHARGES MYLAN WITH MONOPOLIZATION, SEEKS $120 MILLION

FTC v. Mylan Laboratories;

Masin v. Mylan Laboratories

The Federal Trade Commission has charged Mylan Laboratories Inc. and three other drug companies with unlawful restraint of trade, monopolization and conspiracy to monopolize the market for two anti-anxiety drugs after Mylan dramatically hiked the...
End of Document© 2023 Thomson Reuters. No claim to original U.S. Government Works.